OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Más de OpenAI News
- Making it easier for websites to express AI training preferences
- Community safety report and new protections for teens
- Fair use benefits everyone
- An updated Model Spec for more capable and beneficial AI
- How we detect frontier model misalignment
- How Ropes & Gray is developing AI for transactional diligence